| Scrip Code | 524669 |
|---|---|
| NSE Symbol | HESTERBIO |
| MSEI Symbol | NOTLISTED |
| ISIN | INE782E01017 |
| Name of company | HESTER BIOSCIENCES LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 30-01-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 21-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 30-01-2026 10:31:00 |
| End date and time of board meeting | 30-01-2026 11:08:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 7,741.50 | 23,248.90 | |
| Other income | 66.90 | 1,271.20 | |
| Total income | 7,808.40 | 24,520.10 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 1,834.00 | 4,932.50 |
| (b) | Purchases of stock-in-trade | 564.60 | 1,009.10 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (325.80) | 309.30 |
| (d) | Employee benefit expense | 1,551.80 | 4,630.10 |
| (e) | Finance costs | 182.20 | 583.90 |
| (f) | Depreciation, depletion and amortisation expense | 443.10 | 1,296.70 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 2,337.60 | 7,135.40 |
| Total other expenses | 2,337.60 | 7,135.40 | |
| Total expenses | 6,587.50 | 19,897.00 | |
| 3 | Total profit before exceptional items and tax | 1,220.90 | 4,623.10 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 1,220.90 | 4,623.10 |
| 6 | Tax expense | ||
| 7 | Current tax | 269.90 | 741.90 |
| 8 | Deferred tax | 151.50 | 239.10 |
| 9 | Total tax expenses | 421.40 | 981.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 799.50 | 3,642.10 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 131.50 | 451.60 |
| 16 | Total profit (loss) for period | 931.00 | 4,093.70 |
| 17 | Other comprehensive income net of taxes | (40.50) | (169.70) |
| 18 | Total Comprehensive Income for the period | 890.50 | 3,924.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 876.50 | 3,965.60 | |
| Total profit or loss, attributable to non-controlling interests | 54.50 | 128.10 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 836.40 | 3,797.30 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 54.10 | 126.70 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 850.70 | 850.70 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 10.94 | 48.12 | |
| Diluted earnings (loss) per share from continuing operations | 10.94 | 48.12 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 10.94 | 48.12 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 10.94 | 48.12 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Please visit the Company website and stock exchange website for the full PDF of Results |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Poultry Healthcare | 5,111.40 | 14,125.50 | ||||
| 2 | Animal Healthcare | 2,630.10 | 9,123.40 | ||||
| Total Segment Revenue | 7,741.50 | 23,248.90 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 7,741.50 | 23,248.90 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Poultry Healthcare | 1,222.40 | 3,497.40 | ||||
| 2 | Animal Healthcare | 368.40 | 2,031.80 | ||||
| Total Profit before tax | 1,590.80 | 5,529.20 | |||||
| i. Finance cost | 182.20 | 583.90 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 56.20 | (129.40) | |||||
| Profit before tax | 1,352.40 | 5,074.70 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Poultry Healthcare | 26,728.30 | 26,728.30 | ||||
| 2 | Animal Healthcare | 22,389.80 | 22,389.80 | ||||
| Total Segment Asset | 49,118.10 | 49,118.10 | |||||
| Un-allocable Assets | 18,909.70 | 18,909.70 | |||||
| Net Segment Asset | 68,027.80 | 68,027.80 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Poultry Healthcare | 1,971.80 | 1,971.80 | ||||
| 2 | Animal Healthcare | 3,657.00 | 3,657.00 | ||||
| Total Segment Liabilities | 5,628.80 | 5,628.80 | |||||
| Un-allocable Liabilities | 26,404.90 | 26,404.90 | |||||
| Net Segment Liabilities | 32,033.70 | 32,033.70 | |||||
| Disclosure of notes on segments | Textual Information(2) | ||||||
| Textual Information(2) | Please visit the Company website and stock exchange website for the full PDF of Results |
|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement Gain/(Loss) on Defined Benefit Plans | 22.90 | (4.30) |
| Total Amount of items that will not be reclassified to profit and loss | 22.90 | (4.30) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 5.70 | (1.10) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Foreign Currency Translation Reserve | (57.70) | (166.50) |
| Total Amount of items that will be reclassified to profit and loss | (57.70) | (166.50) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | (40.50) | (169.70) |